-
Antengene Appoints Kevin Lynch as Chief Medical Officer
prnasia
March 26, 2021
Antengene Corporation Limited, a leading innovative biopharmaceutical company dedicated to discovering, developing, and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncology, announced the appointment of ...
-
Sirtex Medical appoints Kevin R. Smith as Chief Executive Officer
En-CPhI.CN
October 17, 2019
Sirtex Medical, a leading manufacturer of targeted liver cancer therapies, announced the appointment of Kevin R. Smith as Chief Executive Officer of Sirtex Medical Pty Ltd.
-
GSK picks Kevin Sim to lead business development for pharma R&D
pharmatimes
July 17, 2018
GlaxoSmithKline has named Kevin Sim as senior vice president and head of worldwide business development for pharmaceuticals R&D.
-
GSK picks Kevin Sim to lead business development for pharma R&D
pharmatimes
July 16, 2018
GlaxoSmithKline has named Kevin Sim as senior vice president and head of worldwide business development for pharmaceuticals R&D.
-
GSK picks Kevin Sim to lead business development for pharma R&D
pharmatimes
April 20, 2018
GlaxoSmithKline has named Kevin Sim as senior vice president and head of worldwide business development for pharmaceuticals R&D.
-
GSK Recruiting Score: Genentech's Kevin Sin to Help Drive R&D and M&A
biospace
April 19, 2018
GlaxoSmithKline?Chief Executive Officer Emma Walmsley continues to hone her leadership team with a hire who will focus on potential research and development deals.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight January 2025
